Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series
Pauline Vetter, Christiane S. Eberhardt, Benjamin Meyer, Paola Martinez-Murillo, Giulia Torriani, Fiona Pigny, Sylvain Lemeille, Samuel Cordey, Florian Laubscher, Diem‐Lan Vu, Adrien Calame, Manuel Schibler, Frédérique Jacquérioz, Géraldine Blanchard‐Rohner, Claire-Anne Siegrist, Laurent Kaiser, Arnaud M. Didierlaurent, Isabella Eckerle
Abstract
This work is particularly important because it simultaneously assessed the virology, immunology, and clinical presentation of the same subjects, whereas other studies assess these separately. We describe the detailed viral and immune profiles of the first five patients infected by SARS-CoV-2 and quarantined in Geneva, Switzerland. Viral loads peaked at the very beginning of the disease, and infectious virus was shed only during the early acute phase of disease. No infectious virus could be isolated by culture 7 days after onset of symptoms, while viral RNA was still detectable for a prolonged period. Importantly, we saw that all patients, even those with mild symptoms, mount an innate response sufficient for viral control (characterized by early activated cytokines and monocyte responses) and develop specific immunity as well as cellular and humoral SARS-CoV-2-specific adaptive responses, which already begin to decline a few months after the resolution of symptoms.